PMCA for High-Throughput Detection of Prions using the UIP400MTP Sonicator
The UIP400MTP multi-well plate sonicator offers a powerful solution for high-throughput sample preparation in protein misfolding cyclic amplification (PMCA). By delivering uniform energy distribution across multiple wells and maintaining precise sonication parameters, this system enables the simultaneous processing of numerous samples with exceptional reproducibility. These capabilities are critical for optimizing PMCA to detect prions at low concentrations in challenging biological samples, such as saliva, where assay inhibitors can obscure results.
Prion diseases, such as chronic wasting disease (CWD) in cervids and Creutzfeldt-Jakob disease (CJD) in humans, are neurodegenerative disorders caused by misfolded prion proteins (PrPSc). These diseases often involve low levels of infectious prions in bodily fluids, such as saliva, blood, and urine, complicating diagnosis and research. Horizontal transmission of CWD through prions shed in environmental matrices has particularly significant implications for wildlife management and ecological health. Similarly, in diseases like Creutzfeldt-Jakob disease, reliable amplification of misfolded prion proteins from human samples is crucial for advancing diagnostics and understanding disease progression.

High-Efficiency Protein Misfolding Amplification with the UIP400MTP High-Throughput Sonicator

Protocol for High-Throughput Protein Misfolding Cyclic Amplification (PMCA)
The following protocol allows the efficient processing of high sample number under the exactly same conditions for robust research results.
Sample Preparation
Starting Material:
Prepare samples by:
- Resuspending sarkosyl extraction pellets in PMCA substrate.
- Directly spiking brain homogenates or blood samples with prion seeds.
Substrate:
- Use a 10% (wt/vol) brain homogenate prepared from transgenic mice over-expressing PrPC (e.g., Tg mice).
- Homogenize the brain tissue in:
– 1× PBS.
– 150 mM NaCl.
– 1% Triton X-100. - Store the substrate at -80ºC until use.
Sample Setup in Microplate or Tubes:
Tubes:
- Add 90 μL of brain homogenate substrate and seed with 10 μL of sample (e.g., blood, brain homogenate, or sarkosyl pellet).
- Place 3 Teflon beads (1.59-mm or 2.38-mm diameter) in each 0.2 mL tube.
- Mount the tubes in a rack compatible with the UIP400MTP sonicator.
6-Well Microplate:
- Add 5 mL of brain homogenate substrate and seed with 500 μL of sample per well.
- Add 3 Teflon beads to each well.
PMCA Procedure
Placement:
Place the tube rack or 6-well microplate into the UIP400MTP sonicator according to the manufacturer’s instructions.
Cycling Program:
Perform 144 PMCA cycles as follows:
- Incubation: 29 minutes and 30 seconds at 37°C.
- Sonication: 30 seconds at 60% amplitude.
- Monitor the temperature: Use the pluggable temperature sensor to monitor sample temperature and program the UIP400MTP to a max. temperature of 48–50°C.
Subsequent Rounds:
After completing the first round of 144 cycles, transfer an aliquot of the amplified material:
- Dilute 10-fold into fresh transgenic mouse brain homogenate substrate.
- Perform 96 PMCA cycles for subsequent rounds, maintaining the same sonication parameters.
- Continue for the desired number of rounds (typically up to 5).
Detection of PrPSc
- Proteinase K Digestion:
– Treat samples with Proteinase K (50 μg/mL) at 37°C for 1 hour.
– Terminate digestion by adding SDS-sample buffer and boiling for 10 minutes. - Western Blot Analysis:
– Analyze digested samples using:
– 6H4 or PRC1 anti-PrP antibodies.
– Perform SDS-PAGE and transfer to PVDF membranes for detection.
Process More Samples for More Robust Results
The UIP400MTP multi-well plate sonicator significantly enhances the efficiency and scalability of protein misfolding cyclic amplification (PMCA), addressing the traditionally time-consuming nature of the procedure. By allowing the simultaneous processing of up to 96 samples in a 96-well plate, the system streamlines PMCA workflows while maintaining precise and uniform sonication conditions across all wells. This high-throughput capability minimizes manual handling, reduces labor-intensive steps, and ensures reproducibility, making it an indispensable tool for prion research. Whether investigating chronic wasting disease or Creutzfeldt-Jakob disease, the UIP400MTP facilitates large-scale studies with greater efficiency, enabling researchers to meet the demands of modern diagnostic and scientific applications.
Literature / References
- FactSheet UIP400MTP Multi-well Plate Sonicator – Non-Contact Sonicator – Hielscher Ultrasonics
- Lauren E. Cruchley-Fuge, Martin R. Jones, Ossama Edbali, Gavin R. Lloyd, Ralf J. M. Weber, Andrew D. Southam, Mark R. Viant (2024): Automated extraction of adherent cell lines from 24-well and 96-well plates for multi-omics analysis using the Hielscher UIP400MTP sonicator and Beckman Coulter i7 liquid handling workstation. Metabomeeting 2024, University of Liverpool, 26-28th November 2024.
- De Oliveira A, Cataneli Pereira V, Pinheiro L, Moraes Riboli DF, Benini Martins K, Ribeiro de Souza da Cunha MDL (2016): Antimicrobial Resistance Profile of Planktonic and Biofilm Cells of Staphylococcus aureus and Coagulase-Negative Staphylococci. International Journal of Molecular Sciences 17(9):1423; 2016.
- Martins KB, Ferreira AM, Pereira VC, Pinheiro L, Oliveira A, Cunha MLRS (2019): In vitro Effects of Antimicrobial Agents on Planktonic and Biofilm Forms of Staphylococcus saprophyticus Isolated From Patients With Urinary Tract Infections. Frontiers in Microbiology 2019.
- Dreyer J., Ricci G., van den Berg J., Bhardwaj V., Funk J., Armstrong C., van Batenburg V., Sine C., VanInsberghe M.A., Marsman R., Mandemaker I.K., di Sanzo S., Costantini J., Manzo S.G., Biran A., Burny C., Völker-Albert M., Groth A., Spencer S.L., van Oudenaarden A., Mattiroli F. (2024): Acute multi-level response to defective de novo chromatin assembly in S-phase. Molecular Cell 2024.
- Mochizuki, Chika; Taketomi, Yoshitaka; Irie, Atsushi; Kano, Kuniyuki; Nagasaki, Yuki; Miki, Yoshimi; Ono, Takashi; Nishito, Yasumasa; Nakajima, Takahiro; Tomabechi, Yuri; Hanada, Kazuharu; Shirouzu, Mikako; Watanabe, Takashi; Hata, Kousuke; Izumi, Yoshihiro; Bamba, Takeshi; Chun, Jerold; Kudo, Kai; Kotani, Ai; Murakami, Makoto (2024): Secreted phospholipase PLA2G12A-driven lysophospholipid signaling via lipolytic modification of extracellular vesicles facilitates pathogenic Th17 differentiation. BioRxiv 2024.
- Cosenza-Contreras M, Seredynska A, Vogele D, Pinter N, Brombacher E, Cueto RF, Dinh TJ, Bernhard P, Rogg M, Liu J, Willems P, Stael S, Huesgen PF, Kuehn EW, Kreutz C, Schell C, Schilling O. (2024): TermineR: Extracting information on endogenous proteolytic processing from shotgun proteomics data. Proteomics. 2024.

Microplate Sonicator UIP400MTP for high-throughput PMCA
Frequently Asked Questions
What are Prions?
Prions are misfolded proteins capable of inducing abnormal folding of normal, cellular proteins, particularly in the brain. Unlike bacteria or viruses, prions lack nucleic acids and propagate through a self-templating mechanism, leading to progressive neurodegenerative diseases such as Creutzfeldt-Jakob disease, bovine spongiform encephalopathy (mad cow disease), and scrapie in sheep. Their resistance to standard sterilization processes underscores their unique pathogenicity and poses significant challenges in medical and research settings.
What is the PMCA Technique?
Protein Misfolding Cyclic Amplification (PMCA) is a laboratory technique used to amplify misfolded prion proteins (PrP^Sc) in vitro. It mimics the conversion of normal cellular prion protein (PrP^C) into its misfolded infectious form (PrP^Sc), a hallmark of prion diseases. The process involves cycles of incubation and sonication to accelerate the aggregation of PrP^Sc, making it a powerful tool for detecting low levels of prions.
What Protein Misfolding causes Creutzfeldt Jakob disease?
Creutzfeldt-Jakob disease (CJD) is caused by the misfolding of the prion protein (PrP). The normal isoform (PrPC) adopts an abnormal, β-sheet-rich conformation (PrPSc) that becomes infectious, forming amyloid aggregates in the brain, leading to neurodegeneration.
What is Protein Misfolding Cyclic Amplification of Infectious Prions?
Protein Misfolding Cyclic Amplification (PMCA) is a method to amplify the infectious form of prions (PrPSc) by repeatedly incubating normal PrPC with small amounts of PrPSc. During each cycle, PrPSc catalyzes the misfolding of PrPC, and sonication fragments aggregates, creating more seeding sites. This mimics prion replication in vivo and allows for sensitive prion detection in biological samples.
What Causes PrP to Misfold?
PrP misfolding into the pathogenic PrPSc form can be triggered by:
- Spontaneous misfolding in sporadic prion diseases.
- Genetic mutations in the PRNP gene (e.g., familial prion diseases).
- Exposure to infectious PrPSc via contaminated food, medical procedures, or other means.
- Environmental or structural factors like pH, metal ions, or co-factors that destabilize PrPC.
What is the RT-QuIC Test?
Real-Time Quaking-Induced Conversion (RT-QuIC) is a highly sensitive diagnostic assay for prion diseases. It detects PrPSc by amplifying its ability to convert recombinant PrPC into misfolded aggregates. The test uses fluorescence-based detection of amyloid fibril formation, making it useful for diagnosing diseases like CJD in cerebrospinal fluid (CSF) or other tissues.

Hielscher Ultrasonics manufactures high-performance ultrasonic homogenizers from lab to industrial size.